APA (7th ed.) Citation

Vidal, B., Sebti, J., Verdurand, M., Fieux, S., Billard, T., Streichenberger, N., . . . Zimmer, L. (2016). Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer’s disease: A post-mortem study with PET radiopharmaceuticals. Neuropharmacology, 109, 88-95. https://doi.org/10.1016/j.neuropharm.2016.05.009

Chicago Style (17th ed.) Citation

Vidal, Benjamin, Johan Sebti, Mathieu Verdurand, Sylvain Fieux, Thierry Billard, Nathalie Streichenberger, Claire Troakes, Adrian Newman-Tancredi, and Luc Zimmer. "Agonist and Antagonist Bind Differently to 5-HT1A Receptors During Alzheimer’s Disease: A Post-mortem Study with PET Radiopharmaceuticals." Neuropharmacology 109 (2016): 88-95. https://doi.org/10.1016/j.neuropharm.2016.05.009.

MLA (9th ed.) Citation

Vidal, Benjamin, et al. "Agonist and Antagonist Bind Differently to 5-HT1A Receptors During Alzheimer’s Disease: A Post-mortem Study with PET Radiopharmaceuticals." Neuropharmacology, vol. 109, 2016, pp. 88-95, https://doi.org/10.1016/j.neuropharm.2016.05.009.